Home/Aleta Biotherapeutics/Alan Walts, PhD
AW

Alan Walts, PhD

CEO

Aleta Biotherapeutics

Roles

Co-Founder & Executive ChairmanatAlphaRose Therapeutics

Therapeutic Areas

Aleta Biotherapeutics Pipeline

DrugIndicationPhase
ALETA-001B-cell Lymphoma (Post-CD19 CAR-T relapse)Phase 1/2
ALETA-004Acute Myeloid Leukemia (AML)Preclinical
ALETA-005Multiple MyelomaDiscovery
ALETA-002Solid TumorsDiscovery
ALETA-003Solid TumorsDiscovery